Aidos Innovations Society

What Aidos Innovations Society does

Aidos Innovations Society is a nonprofit translational-science institute headquartered in Vancouver, British Columbia, that develops analytical tools, detection technologies, and therapeutic candidates for substance use disorder and adjacent public health applications. Its core technology stack combines an AI-powered analytical platform with novel molecular-labeling methods and portable electrochemical sensor technology, deployed across three domains: Track & Trace (molecular labeling and drug-supply intelligence to identify new substances and map distribution patterns), Opioid Use Detection (portable, ultra-sensitive sensors for faster treatment and overdose prevention), and Novel Therapeutics (non-opioid pain solutions and next-generation medications to reduce cravings). Underlying sample processing is performed via robotic technology developed in collaboration with the University of British Columbia, and the AI dashboard layer is delivered through an exclusive partnership with Redwood AI.

The organization is led by Managing Director Dr. Matthew A. Roberts, an Adjunct Professor of Psychiatry at UBC with over 25 years in biotechnology and translational medicine, together with four directors covering addiction medicine (Dr. Pouya Azar), electrochemical sensors (Prof. Dan Bizzotto), pharmaceutical synthesis (Dr. Glenn Sammis), and hospital-based mental health and substance use services (Dr. Jesse Sidhu). Aidos does not generate revenue through commercial product pricing; its funding model is grant-based, with disclosed inflows of C$600,000 over two years from the Government of British Columbia for the Track and Trace pilot and up to C$240,000 via Redwood AI from the NRC IRAP Defense Industry Assist program for the Q-SAFE project.

Its customer and partner base is concentrated in government, academic, and clinical institutions — RCMP, Victoria Police Department, Canada Border Services Agency, B.C. Ministries of Public Safety and Health, UBC, Harvard Medical School, UCSF, Vancouver Coastal Health, and VGH and UBC Hospital Foundation. Distribution is direct-to-institution; there is no paid marketing, sales motion, or SMB customer base, and visibility is driven by earned media coverage of public-health initiatives rather than outbound commercial activity.

Name

Aidos Innovations Society

Legal name

Aidos Innovations Society

Website

https://aidosinnovations.ai

Company type

Private

Operating status

Operating

Short description

Aidos Innovations Society is a Vancouver-based nonprofit translational-science institute that develops AI-powered drug-supply intelligence, molecular labeling, electrochemical opioid sensors, and non-opioid therapeutics for law enforcement and public health agencies addressing substance use disorder.

Ownership category

akta.pro rank

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Core offering

Aidos Innovations Society is a nonprofit translational science institute that develops and deploys technologies for substance use disorder and public health applications. Its core offerings comprise an AI-powered analytical drug supply mapping platform (Track & Trace), portable electrochemical opioid detection technologies, and early-stage non-opioid therapeutics research. Programs are delivered through partnerships with government, law enforcement, hospital systems, and academic institutions in British Columbia.

Product overview

Aidos Innovations Society is a nonprofit institute focused on translational medicine in addiction. The organization operates across three domains: (1) Track & Trace - a molecular labeling initiative supporting drug supply identification and forensic intelligence; (2) Opioid Use Detection - portable ultra-sensitive detection technologies for faster treatment and overdose prevention; and (3) Novel Therapeutics - developing non-opioid pain solutions and next-gen medications to reduce cravings. The company also collaborates with Redwood AI as the exclusive artificial intelligence partner for the Track and Trace program, which uses AI-powered analytical platforms to translate laboratory and field data into actionable insights for law enforcement and public health agencies.

Differentiator

Problem solved

Functional benefit

Products and services

• Track & Trace Molecular labeling and AI-powered analytical platform that identifies changes in drug supply, detects new substances, determines drug origin and distribution, and maps how harmful compounds move through communities; delivers actionable drug supply intelligence and early warning to law enforcement and public health agencies.
• Opioid Use Detection Portable, ultra-sensitive technologies that detect and quantify opioid presence (including fentanyl) for faster treatment and overdose prevention, deployed across Vancouver and Victoria, British Columbia.
• Novel Therapeutics Translational research and development of non-opioid pain solutions and next-generation medications designed to reduce cravings, improve outcomes, and restore lives for those suffering from substance use disorder.

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and flagship.

• Redwood AIcoreTechnology or Integration · 17 April 2026Redwood AI serves as the exclusive artificial intelligence partner in the Track and Trace program, providing AI technology to translate complex laboratory and field data into actionable insights. The company developed dashboard tools to help public health and safety agencies visualize chemical and geographic trends in the drug supply.
• Vancouver Coastal HealthcoreStrategic or Co-development Partner · 17 April 2026Vancouver Coastal Health contributes clinical expertise in mental health and substance use services, supporting the healthcare delivery perspective in the translational science model.
• Royal Canadian Mounted Police (RCMP)coreImplementation/ SI/ Consulting Partner · 17 April 2026RCMP participates as a law enforcement partner in the Track and Trace program, contributing to drug intelligence gathering and coordinated public safety responses across jurisdictions.
• Victoria Police DepartmentcoreImplementation/ SI/ Consulting Partner · 17 April 2026Victoria Police Department collaborates in the Track and Trace initiative to provide earlier detection of emerging drug threats and coordinated public safety responses in the Victoria area.
• Canada Border Services Agency (CBSA)coreImplementation/ SI/ Consulting Partner · 17 April 2026CBSA participates in the Track and Trace program to support broader border security use cases and coordinated responses to illicit drug trafficking.
• University of British Columbia (UBC)coreStrategic or Co-development PartnerUBC researchers, including Prof. Dan Bizzotto (Chemistry) and Prof. Glenn Sammis (Chemistry), contribute expertise in electrochemical sensor technology and pharmaceutical synthesis. UBC hosts the robotic technology and laboratory facilities for the Track and Trace program.
• VGH and UBC Hospital FoundationcoreStrategic or Co-development PartnerFoundation partner providing funding support and institutional backing for the Track and Trace initiative and broader translational science programs.
• Harvard Medical SchoolflagshipStrategic or Co-development PartnerAcademic partnership contributing expertise in translational medicine and addiction research to support the nonprofit's mission of translating science into clinical solutions.
• University of California, San Francisco (UCSF)flagshipStrategic or Co-development PartnerAcademic partnership providing expertise in addiction medicine and translational science research, collaborating on solutions for substance use disorder.
• B.C. Ministries of Public Safety and HealthcoreImplementation/ SI/ Consulting PartnerGovernment ministries providing funding and institutional support for the Track and Trace program, contributing to policy alignment and public health coordination.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Agilent Technologies: Major analytical instruments manufacturer with chromatography, mass spectrometry, and spectroscopy used in forensic and clinical chemistry labs. Comparable technology stack for the analytical chemistry layer behind Aidos's Track and Trace platform.
• Bruker Corporation: Major analytical chemistry instruments manufacturer including mass spectrometry and chromatography widely used in forensic chemistry and clinical toxicology. Comparable underlying technology base for drug supply analysis even though Bruker operates as a broad instrumentation incumbent rather than a focused drug-intelligence vendor.
• Shimadzu: Major analytical chemistry instruments manufacturer including chromatography and mass spectrometry systems widely used in forensic toxicology and clinical chemistry. Comparable analytical chemistry technology base to the instrumentation that supports drug supply analysis.

Direct peers

• Quit Genius: Digital therapeutic for tobacco, alcohol, and opioid use disorder, now operating under the Pelago umbrella. Comparable as a digital SUD intervention platform and a potential acquirer/strategic partner for Aidos's novel therapeutics efforts.
• Ria Health: Telehealth provider for alcohol use disorder offering medication-assisted treatment and digital coaching. Comparable digital SUD treatment model for a related indication; useful as a peer for understanding technology-enabled addiction care economics.
• Workit Health: Telehealth substance use disorder treatment platform offering virtual counseling and medication-assisted treatment. Comparable in digital delivery of SUD care, including opioid use disorder treatment that overlaps Aidos's opioid focus.
• Pelago Health: Digital substance use management platform serving employers and health plans. Comparable as a digital SUD care provider with similar emphasis on evidence-based, scalable treatment for opioid and other substance use disorders.
• Bicycle Health: Telehealth provider focused on medication-assisted treatment for opioid use disorder. Comparable in its focus on expanding evidence-based care access for substance use disorder, though commercial rather than nonprofit.
• ODMap: Drug overdose surveillance system operated by the Washington/Baltimore High Intensity Drug Trafficking Areas program. Maps overdoses geographically in near real-time for public health and law enforcement - directly comparable mission to Aidos's Track and Trace drug intelligence platform.
• Sonara Health: Medication adherence monitoring platform for opioid use disorder treatment. Comparable in deploying technology to support opioid agonist therapy adherence, a core clinical use case within Aidos's substance use disorder portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aidos Innovations Society